Delivery Order SPE2DB24D9113-SPE2DB25FEPWU

Award Date 2/27/25
Potential Completion Date 2/28/25
Potential Value $18K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award made by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $18,526.82, is a firm fixed-price delivery order for the pharmaceutical product Trikafta. This award is part of a larger Indefinite Delivery Contract (IDC) with DMS Pharmaceutical Group valued at $499,999,999, which allows the DLA to issue delivery orders for a comprehensive...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is a delivery order valued at $18,488.12 for the pharmaceutical product Trikafta 100-50-75 mg/150 mg. The contract has a period of performance ending on February 27, 2025 and is a firm fixed-price contract. DMS Pharmaceutical Group Inc. holds a larger $499,999,999 Indefinite Delivery...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $18,526.83 firm fixed-price delivery order is for the supply of Trikafta, a specialized prescription medication. This award is issued under DMS Pharmaceutical Group's $499,999,999 Indefinite Delivery Contract (IDC) with the DLA, which enables the agency to place orders for a wide range of branded...
The U.S. Defense Logistics Agency (DLA) awarded a $18,526.83 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. This order for the drug Trikafta is being fulfilled under a larger single-award indefinite delivery contract (IDC), valued up to $499,999,999, awarded to DMS by the DLA. The IDC, which runs through December 31, 2025, allows the DLA to issue delivery orders for a comprehensive range of...
This federal contract award, valued at $37,053.68, was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is a delivery order under an indefinite delivery contract (IDC) valued at up to $499,999,999 that DMS Pharmaceutical Group holds with the DLA. This IDC, under the SPE2DB program, allows the DLA to issue firm fixed-price delivery orders for a comprehensive range of...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $18,526.83 firm fixed-price delivery order is for the specialized medication Trikafta, with an ultimate completion date of October 17, 2024. The contract is not associated with a set-aside designation. DMS Pharmaceutical Group Inc. holds a single-award Indefinite Delivery Contract (IDC) worth...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The award, valued at $73,275.04, is a firm fixed-price delivery order contract for the provision of Trikafta 100-50-75 mg/150 mg tablets. DMS Pharmaceutical Group Inc. holds a $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which enables the agency to issue...
This is a federal contract award from the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is a $55,580.49 firm fixed-price delivery order under DMS Pharmaceutical Group's existing $499,999,999 Indefinite Delivery Contract (IDC) with the DLA. The delivery order is for the pharmaceutical product Trikafta, a specialized medication used to treat cystic fibrosis. The contract has an...
The federal contract award is valued at $55,580.49 and was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The award is a delivery order under a larger indefinite delivery contract (IDC) valued up to $499,999,999 that DMS Pharmaceutical Group holds with DLA. This single-award IDC, under the SPE2DB program, allows DLA to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical...
This federal contract award, valued at $18,318.75, was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The award is a delivery order under a larger indefinite delivery contract (IDC) with the DLA, valued at up to $499,999,999, which runs through December 31, 2025. This IDC allows the DLA to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical items,...
  • SPE2DB24D9113
    Indefinite Delivery Contract
  • SPE2DB24D9113-SPE2DB25FEPWU
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $18,488.12, is a firm fixed-price delivery order for the pharmaceutical product Trikafta. This contract is part of a larger Indefinite Delivery Contract (IDC) between DMS Pharmaceutical Group and the DLA, valued at $499,999,999 and valid through November 2026. The IDC enables the DLA to issue delivery orders for a comprehensive range of pharmaceutical items, including branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables, to support the medical supply needs of military health facilities worldwide. This contract award is not associated with any set-aside designation.

Generated 6/1/25, 3:20 AM